The journey of a generic drug developer is a complex and multifaceted one, involving rigorous research, meticulous development, and stringent […]
Source
The pharmaceutical excipients market is undergoing rapid transformation, driven by evolving drug formulation needs and technological advancements. As the industry pushes towards more effective, patient-centric, and efficiently manufactured medications,…
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
Expiring drug patents are continuously driving innovation, as branded firms seek out new high-margin opportunities. Examining the patent expirations by […]
Source
Drugs facing the most patent expirations this year Read Post »
Biotechnology: Innovations in Renewable Energy Production Biotechnology has emerged as a crucial player in the transition towards a sustainable energy
Biotechnology: Innovations in Renewable Energy Production Read Post »
The Power of Patent Licensing: Unlocking Innovation and Access to Medicines Patent licensing agreements have become a crucial tool in […]
Source
Excipients, once considered mere inactive ingredients in pharmaceutical formulations, are now recognized as crucial components that can significantly impact drug absorption and bioavailability. As the pharmaceutical industry continues to grapple with p…
The Critical Role of Excipients in Enhancing Drug Absorption Read Post »
Annual Drug Patent Expirations for AUSTEDO+XR Austedo Xr is a drug marketed by Teva and is included in one NDA. […]
Source
Annual Drug Patent Expirations for SOHONOS Sohonos is a drug marketed by Ipsen and is included in one NDA. It […]
Source
Annual Drug Patent Expirations for AUSTEDO Austedo is a drug marketed by Teva Branded Pharm and Teva and is included […]
Source
Get new actionable insights and updates from BiotechBlog
